Ischemic disorder-promoting polypeptide

Details for Australian Patent Application No. 2011222224 (hide)

Owner Fuso Pharmaceutical Industries, Ltd.

Inventors Wakamiya, Nobutaka; Otani, Katsuki

Agent Cullens

Pub. Number AU-A-2011222224

PCT Pub. Number WO2011/108281

Priority 2010-047335 04.03.10 JP

Filing date 4 March 2011

Wipo publication date 9 September 2011

International Classifications

C12N 15/09 Mutation or genetic engineering - Recombinant DNA-technology

C07K 14/47 Peptides having more than 20 amino acids

Event Publications

20 September 2012 PCT application entered the National Phase

  PCT publication WO2011/108281 Priority application(s): WO2011/108281

11 October 2012 Amendment Made

  The nature of the amendment is: Amend the invention title to read Polypeptide Acting To Enhance Ischemic Diseases

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011222243-Artificial skin

2011222198-Method for manufacturing a regenerated Fischer-Tropsch synthesis catalyst, and hydrocarbon manufacturing method